Harshraj Leuva

Harshraj Leuva

Oncology | Hematology

2510 Bellevue Medical Center Drive
Suite 250
Bellevue, NE 68123

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Early treatment outcome prediction in metastatic castration-resistant prostate cancer utilizing 3-month tumor growth rate (g-rate) based machine learning model.

Early treatment outcome prediction in metastatic castration-resistant prostate cancer utilizing 3-month tumor growth rate (g-rate) based machine learning model.

Journal: medRxiv : the preprint server for health sciences

Published: March 23, 2026

Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer.

Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer.

Journal: JAMA network open

Published: November 04, 2025

NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025.

NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 09, 2025

Talazoparib in Patients With Solid Tumors With BRCA1/2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study.

Talazoparib in Patients With Solid Tumors With BRCA1/2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study.

Journal: JCO precision oncology

Published: June 12, 2024

Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer.

Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer.

Journal: Seminars in oncology

Published: March 06, 2024

Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses.

Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses.

Journal: EBioMedicine

Published: June 27, 2023

Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans.

Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans.

Journal: Seminars in oncology

Published: July 18, 2022

Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.

Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.

Journal: Leukemia

Published: October 01, 2021

A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide.

A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide.

Journal: Seminars in oncology

Published: November 06, 2019

Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.

Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.

Journal: The New England journal of medicine

Published: April 20, 2017

Adrenocortical Cancer: A Molecularly Complex Disease Where Surgery Matters.

Adrenocortical Cancer: A Molecularly Complex Disease Where Surgery Matters.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 12, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026